|  Help  |  About  |  Contact Us

Publication : Par-4 downregulation promotes breast cancer recurrence by preventing multinucleation following targeted therapy.

First Author  Alvarez JV Year  2013
Journal  Cancer Cell Volume  24
Issue  1 Pages  30-44
PubMed ID  23770012 Mgi Jnum  J:199068
Mgi Id  MGI:5500814 Doi  10.1016/j.ccr.2013.05.007
Citation  Alvarez JV, et al. (2013) Par-4 Downregulation Promotes Breast Cancer Recurrence by Preventing Multinucleation following Targeted Therapy. Cancer Cell 24(1):30-44
abstractText  Most deaths from breast cancer result from tumor recurrence, but mechanisms underlying tumor relapse are largely unknown. We now report that Par-4 is downregulated during tumor recurrence and that Par-4 downregulation is necessary and sufficient to promote recurrence. Tumor cells with low Par-4 expression survive therapy by evading a program of Par-4-dependent multinucleation and apoptosis that is otherwise engaged following treatment. Low Par-4 expression is associated with poor response to neoadjuvant chemotherapy and an increased risk of relapse in patients with breast cancer, and Par-4 is downregulated in residual tumor cells that survive neoadjuvant chemotherapy. Our findings identify Par-4-induced multinucleation as a mechanism of cell death in oncogene-addicted cells and establish Par-4 as a negative regulator of breast cancer recurrence.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

13 Bio Entities

Trail: Publication

0 Expression